75%Confidence
0Views
FDASource
2026-04-07Date
Summary
Annora Pharma's Class III recall for cross-contamination of Pitavastatin tablets reveals packaging errors that, while lower risk, point to significant quality control failures. This could erode trust in Northstar Rx's products and necessitate supplier re-evaluation.
Actionable: Review Northstar Rx's quality agreements with Annora Pharma to enforce stricter packaging controls.
AI Confidence: 75%
Data Points
firmAnnora Pharma Private Limited
classificationClass III
statusOngoing
distributionTN
productPitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Phar
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now